Skip to main content

GALT Competitors

profileAnalyst coverage5 yr. financialspremium researchdividendsadv. chartsearningsoptionsprice historyeventsinsiders

Galectin Therapeutics Inc. News

5 Top Stock Gainers for Friday: Stamps.com, Galectin, GM

Stamps.com, Galectin Therapeutics, General Motors, Far Peak Acquisition and Carver Bancorp are five top stock gainers for Friday.

Galectin Therapeutics Soars on Positive Melanoma Treatment Data

Galectin Therapeutics jumps after positive data from its melanoma treatment.

Galectin therapeutics (galt) stock drops on drug failure, downgraded

H.C. Wainwright reduced Galectin Thereapeutics' (GALT) stock rating to 'neutral' after the company's fatty liver disease drug failed in a phase II clinical trial.

Galectin therapeutics (galt) stock declines on drug failure, rating cut

Galectin Therapeutics' (GALT) stock rating was cut two notches to 'sell' at Roth Capital on Wednesday after the company's drug for fatty liver disease failed a clinical trial.

Top Swing Trade Ideas for Monday: Cerus, Endocyte, More

Cerus, Endocyte and Galectin Therapeutics are our big swing trades for Monday. So, how should investors buy and sell?

Breaking News

Disney Mobile Game Opens Up a New Universe

Familiar Disney characters populate an alternate reality in new interactive game.

Birth Control Stocks May Benefit From the Reversal of Roe v. Wade

The historic Supreme Court decision may force women to make different choices.

Barstool's Portnoy Takes a Surprising Stand on a Key Political Issue

The outspoken Republican with a platform voices his opinion on the state of democracy moving to the right.

McDonald's Brings Back a Classic Menu Item (with a Catch)

You never know what the fast-food chain might bring back or create a new version of.